Pacira BioSciences, Inc. PCRX Business Segments — Pre-Tax Income
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Pacira BioSciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest.
The official record: Pacira BioSciences, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pacira BioSciences, Inc.'s business segments — pre-tax income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Pacira BioSciences, Inc.'s business segments — pre-tax income?
- Pacira BioSciences, Inc. (PCRX) reported business segments — pre-tax income of $5M in Q1 2026.
- How has Pacira BioSciences, Inc.'s business segments — pre-tax income changed year-over-year?
- Pacira BioSciences, Inc.'s business segments — pre-tax income decreased by 42.6% year-over-year, from $8.71M to $5M.
- What does business segments — pre-tax income mean?
- This metric measures the profitability of the reportable segment after accounting for all operating and non-operating expenses, but before the deduction of income tax provisions. It serves as a primary indicator of the segment's underlying operational performance and financial health. Investors use this to evaluate the segment's ability to generate earnings from its core business activities.